Plain English Summary
Background and study aims
Research has shown that people with lung cancer often wait for several months after first noticing symptoms, and this can make it more difficult to treat the disease. This study explores ways in which online information about lung cancer symptoms can be presented to encourage people to see their doctor earlier. Lung cancer patients were interviewed in an earlier study and some of them had used the Internet to look up their symptoms, and this influenced their decision to see their doctor. A website about lung cancer has been designed to encourage people to see their doctor earlier when they have worrying symptoms. This new website uses psychological techniques to influence peoples' beliefs about going to their doctor. The aim of this study is to compare this new website against other versions of the website which don't use these psychological techniques, to see if they have any effect on peoples' intention to make an appointment to have their symptoms checked.
Who can participate?
Patients aged over 18 with possible lung cancer symptoms (e.g., long-standing cough, feeling out of breath, discomfort in the chest, shoulder or back)
What does the study involve?
Participants are randomly allocated to one of four groups, to receive information about lung cancer that is either tailored to individual users (based on their age, smoking and reported symptoms) or not, and that either includes components based on psychological techniques or does not.
Intervention Group: Information is tailored and includes psychological components
Control Group 1: Information is untailored and includes psychological components
Control Group 2: Information is tailored and does not include psychological components
Control Group 3: Information is untailored and does not includes psychological components
All participants are followed up 3 weeks later to assess their intention to seek medical help.
What are the possible benefits and risks of participating?
It is not known whether the study will help the participants but they may find the information provided on the website useful in deciding whether to see a GP about their symptoms. It is not the aim to ask any questions or provide any information that might be upsetting or stressful, but some participants may feel worried about lung cancer after viewing information on our website.
Where is the study run from?
University of Manchester (UK)
When is the study starting and how long is it expected to run for?
March 2017 to December 2017
Who is funding the study?
Medical Research Council (UK)
Who is the main contact?
Ms Julia Mueller
Ms Julia Mueller
LF1. Kilburn Building
University of Manchester
Evaluation of a Web-based intervention to encourage early help-seeking in people with symptoms indicative of lung cancer: a randomised controlled trial
The aim of the study is to determine whether information tailoring, and addition of theory-based components to information about lung cancer impacts on individuals' intention to seek medical help.
1. Pilot study: University Research Ethics Committee 1 (University of Manchester), 30/09/2015, ref: 15353
2. Full trial: University Research Ethics Committee 1 (University of Manchester), 29/03/2017, amendment ref: 2017-1224-2093
2x2 randomised factorial design
Primary study design
Secondary study design
Randomised controlled trial
Patient information sheet
Available via www.when2go-study.co.uk
The intervention consists of information about lung cancer symptoms, risk factors and a recommendation of when medical advice should be sought. The information is tailored to individual users (based on their age, smoking status and reported symptoms) and also includes components based on psychological theory, to target beliefs people hold about help-seeking. Thus this intervention involves two factors: information tailoring and presence of theory-based components. It is designed to encourage help-seeking for potential lung cancer symptoms.
Participants are randomised to the four study groups using a block randomisation procedure (in blocks of two):
Intervention Group: Information is tailored, and includes theory-based components
Control Group 1: Information is untailored, and includes theory-based components
Control Group 2: Information is tailored, and does not include theory-based components
Control Group 3: Information is untailored, and does not includes theory-based components
For each study group, the intervention duration is approximately 15 minutes. All participants are followed up 3 weeks after the intervention.
Primary outcome measure
1. Intention to seek medical help, measured on an 11-point scale at baseline pre-treatment and immediately post-treatment, and, if applicable, at 3 week follow-up. Intention will not be measured again at follow-up if participants report already having sought help at this point
2. Reported help-seeking, measured by asking participants whether they have discussed their symptoms with a health professional (yes/no) at 3-week follow-up
Secondary outcome measures
1. Beliefs and attitudes towards help-seeking, measured using Theory of Planned Behaviour questionnaire at baseline, post-treatment
2. Cancer risk perception, measured using a single item with a 7-point scale at baseline, post-treatment
Overall trial start date
Overall trial end date
Reason abandoned (if study stopped)
Participant inclusion criteria
1. Over the age of 18
2. Lives in the UK
3. Experiencing any of the following symptoms:
3.1. A cough (whether dry and tickly or with phlegm)
3.2. A long-standing cough that changes or gets worse
3.3. Feeling out of breath
3.4. Discomfort in the chest, shoulder or back
3.5. Coughing up phlegm with a blood in it (even if just a few specks)/spitting blood
3.6. Changes in your voice
3.7. Unexplained weight loss or unexplained loss of appetite
3.8. Swelling of face and neck
3.9. Persistent/recurring chest infection
3.10. Tiredness or lack of energy
3.11. Changes in the appearance of fingers or fingernails (such as a softening of the nailbed, stronger than normal curving of the fingernails, or thickening of the fingertips so that the shape looks like an upside down spoon)
Target number of participants
Participant exclusion criteria
1. Individuals under the age of 18
2. Individuals who do not live in the UK
3. Individuals who are not experiencing any relevant symptoms
Recruitment start date
Recruitment end date
Countries of recruitment
Trial participating centre
University of Manchester
Medical Research Council
Funding Body Type
Funding Body Subtype
Results and Publications
Publication and dissemination plan
Planned publication in a high-impact peer reviewed journal and in a PhD dissertation, approximately 1 year after completion of the trial.
IPD sharing statement as of 12/12/2018:
The datasets generated during and/or analysed during the current study are not expected to be made available as the ethics documentation does not state that data will be shared in a public repository.
Previous IPD sharing statement:
The current data sharing plans for the current study are unknown and will be made available at a later date.
Intention to publish date
Participant level data
Not expected to be available
Basic results (scientific)
See additional file (ISRCTN70042662_BasicResults_11Dec18.pdf)
- ISRCTN70042662_BasicResults_11Dec18.pdf Uploaded 11/12/2018